Aardvark Therapeutics, Inc. (AARD) stock
AARDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.15−0.11 (-8.73%)
Close on Nov 17, 2026Market cap $25.17MP/E –Yield –
Aardvark Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Aardvark Therapeutics's enterprise value was -$39.10M on Nov 11, 2026, against $90.62M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$39.10M | -124.6% |
| 2025 | Dec 31, 2025 | $159.01M | – |
See a number that looks wrong?